Progressive relapsing multiple sclerosis and Malaise

Summary:

Malaise is found among people with Progressive relapsing multiple sclerosis, especially for people who are female, 40-49 old.

The study analyzes which people have Malaise with Progressive relapsing multiple sclerosis. It is created by eHealthMe based on reports of 23 people who have Progressive relapsing multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Progressive relapsing multiple sclerosis?

Progressive relapsing multiple sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord or both) is found to be associated with 16 drugs and 38 conditions by eHealthMe. Check the latest studies of Progressive relapsing multiple sclerosis.

What is Malaise?

Malaise (a feeling of general discomfort or uneasiness) is found to be associated with 3,525 drugs and 5,118 conditions by eHealthMe. Check the latest studies of Malaise.

On Jul, 10, 2026

23 people who have Progressive Relapsing Multiple Sclerosis and Malaise are studied.

Would you have Malaise when you have Progressive relapsing multiple sclerosis?

Gender of people who have Progressive Relapsing Multiple Sclerosis and experienced Malaise *:

female: 90.91 %
male: 9.09 %

Age of people who have Progressive Relapsing Multiple Sclerosis and experienced Malaise *:

Common co-existing conditions for these people *:

Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 7 people, 30.43%
Stress And Anxiety: 4 people, 17.39%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 13.04%
Hyperthyroidism (over activity of the thyroid gland): 2 people, 8.70%
High Blood Pressure: 2 people, 8.70%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 4.35%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 4.35%
Progressive Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord): 1 person, 4.35%

Common drugs taken by these people *:

Common symptoms for these people *:

Balance Disorder: 12 people, 52.17%
Weakness: 10 people, 43.48%
Gait Disturbance: 10 people, 43.48%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 39.13%
Fatigue (feeling of tiredness): 8 people, 34.78%
Drug Ineffective: 8 people, 34.78%
Hypoaesthesia (reduced sense of touch or sensation): 7 people, 30.43%
Dyspnea (difficult or laboured breathing): 7 people, 30.43%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 30.43%
Foot Deformity (functional disability of foot): 7 people, 30.43%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Malaise?

- Check whether Malaise is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Progressive relapsing multiple sclerosis (526 reports)
Malaise (529,933 reports)

All the drugs that are associated with Malaise:

Malaise (3,525 drugs)

All the conditions that are associated with Malaise:

Malaise (5,118 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Malaise and Progressive relapsing multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.